過敏性鼻炎治療市場：按治療類型、給藥途徑、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030 年

過敏性鼻炎是一種由 IgE 介導的疾病，由過敏原引起，例如黴菌和鼻涕、動物皮屑、□蟲、雜草花粉和草。 有兩種類型的過敏性鼻炎，季節性和常年性，它們會在鼻子中引起輕度、中度至重度炎症。 過敏性鼻炎的主要症狀包括鼻塞、流鼻涕、打噴嚏、鼻癢、眼睛發癢、鼻塞、頭痛、鼻子和臉頰有壓迫感、耳朵充血、喉嚨痛、流淚、充血、浮腫、黑眼圈在眼睛和氣味下。 過敏性鼻炎也可能與哮喘和濕疹並存。 過敏性鼻炎和鼻竇炎是有關係的，因為過敏性鼻炎堵住了鼻子，堵住了鼻竇。 過敏性鼻炎有多種治療方法，包括類固醇噴霧劑、抗組胺藥、減充血劑、白三烯抑製劑、過敏注射劑和舌下含片。 過敏性鼻炎可引起鼻息肉（鼻道和鼻竇中異常但非癌性的液囊）、鼻竇炎（由鼻子發炎或腫脹引起的感染）和中耳感染等並發症。

市場動態

為推進過敏原免疫療法研究而加強的研究合作預計將在預測期內推動市場增長。 例如，2021 年 7 月，全球領先的過敏原免疫療法醫療保健公司之一 Stallergenes Greer 宣布與位於法國斯特拉斯堡大學醫院的合同研究機構 Alyatec 開展研究合作。 通過此次合作，Starergenes Glia 將利用 Ariatech 在研究和臨床服務方面的能力，專注於基於精準醫學的方法和過敏患者的管理。

這項研究的主要特點

• 本報告對全球過敏性鼻炎藥物市場進行了深入分析，顯示了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。I'我在這裡。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、主要亮點、績效和戰略等參數介紹全球過敏性鼻炎治療市場主要參與者的概況。
• 本研究涵蓋的主要公司包括Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company, Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer AG, Dr. Reddy's Laboratories Ltd, ALK-Abello A/S, Revolo Biotherapeutics among other prominent players 等知名企業
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 《全球過敏性鼻炎治療藥物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球過敏性鼻炎治療市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按治療類型分類
  • 按給藥途徑劃分的市場概況
  • 市場概況：按銷售渠道
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 給藥途徑總結
• 監管場景
• 品牌分析
• 害蟲分析
• 搬運工分析

第 4 章。過敏性鼻炎治療的全球市場——冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 對供需的影響
• COVID-19 對市場的影響

第 5 章全球過敏性鼻炎藥物市場：按治療類型分類，2017-2030

• 免疫療法
• 科學與技術學院
• SLITD
• 斯利特
• 抗組胺藥
• 減充血劑
• 白三烯受體拮抗劑
• 腎上腺皮質類固醇

第 6 章全球過敏性鼻炎藥物市場：按給藥途徑，2017-2030

• 口服劑
• 鼻內
• 眼內
• 靜脈給藥

第 7 章。過敏性鼻炎治療的全球市場：按分銷渠道，2017-2030

• 零售藥房
• 醫院藥房
• 電子商務

第 8 章過敏性鼻炎治療的全球市場：（按地區）2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• AstraZeneca
• GSK plc.
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Mylan N.V.
• Aytu BioPharma, Inc.
• Glenmark Pharmaceuticals Ltd
• Himalaya Wellness Company
• Regeneron Pharmaceuticals Inc.
• Allergy Therapeutics
• Stallergenes Greer
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• ALK-Abello A/S
• Revolo Biotherapeutics

第 10 章

• 調查方法
• 關於出版商

Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, itchy eyes, stuffy nose, headache, pressure in the nose and cheeks, ear fullness and popping, sore throat, watery, red, or swollen eyes, dark circles under your eyes, trouble smelling, etc. Allergic rhinitis can also be associated with asthma and eczema. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. Various treatments are available for allergic rhinitis which includes nasal steroid sprays, antihistamines, decongestants, leukotriene inhibitors, allergy shots or sublingual tablets, etc. Allergic rhinitis can lead to complications in some cases such as nasal polyps- abnormal but non-cancerous (benign) sacs of fluid that grow inside the nasal passages and sinuses, sinusitis - an infection caused by nasal inflammation and swelling and middle ear infections.

Market Dynamics

Increasing collaborations for advancing research in allergen immunotherapy is expected to propel the market growth during the forecast period. For instance, in July 2021, Stallergenes Greer, one of the global healthcare companies specializing in allergen immunotherapy, announced a research collaboration with Alyatec, a contract research organization based in Strasbourg University Hospital (France). In this collaboration, Stallergenes Greer is focused on a precision medicine-based approach and the management of patients with allergies with the help of Alyatec's competencies in research and clinical services.

Key features of the study:

• This report provides in-depth analysis of the global allergic rhinitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc. Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Glenmark Pharmaceuticals Ltd, Himalaya Wellness Company, Regeneron Pharmaceuticals Inc., Allergy Therapeutics, Stallergenes Greer, Bayer AG, Dr. Reddy's Laboratories Ltd, ALK-Abello A/S, Revolo Biotherapeutics among other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global allergic rhinitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market

Detailed Segmentation:

• Global Allergic Rhinitis Treatment Market, By Treatment Type:
  • Immunotherapy
    • SCIT
    • SLITD
    • SLITT
  • Anti-histamines
  • Decongestants
  • Leukotriene Receptor Antagonists
  • Corticosteroids
• Global Allergic Rhinitis Treatment Market, By Route of Administration:
  • Oral
  • Nasal
  • Intraocular
  • Intravenous
• Global Allergic Rhinitis Treatment Market, By Distribution Channel:
  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce
• Global Allergic Rhinitis Treatment Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Merck & Co., Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Glenmark Pharmaceuticals Ltd
  • Himalaya Wellness Company
  • Regeneron Pharmaceuticals Inc.
  • Allergy Therapeutics
  • Stallergenes Greer, Bayer AG
  • Bayer AG
  • Reddy's Laboratories Ltd
  • ALK-Abello A/S
  • Revolo Biotherapeutics

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Route of Administration Overview
• Regulatory Scenario
• Brand Analysis
• PEST Analysis
• Porter's Analysis

4. Global Allergic Rhinitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• SCIT
• SLITD
• SLITT
• Anti-histamines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Decongestants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Leukotriene Receptor Antagonists
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intraocular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Intravenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• E-Commerce
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Allergic Rhinitis Treatment Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim International GmbH
• AstraZeneca
• GSK plc.
• Johnson & Johnson Services, Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Mylan N.V.
• Aytu BioPharma, Inc.
• Glenmark Pharmaceuticals Ltd
• Himalaya Wellness Company
• Regeneron Pharmaceuticals Inc.
• Allergy Therapeutics
• Stallergenes Greer
• Bayer AG
• Dr. Reddy's Laboratories Ltd.
• ALK-Abello A/S
• Revolo Biotherapeutics

10. Section

• Research Methodology
• About Us